AngioLab, Inc. is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company is involved in the manufacturing and sale of pharmaceuticals and functional health food. The pharmaceuticals include obesity treatment, retinopathy treatment, periodontal disease treatments, otitis media treatments, and psoriasis treatments. The functional health food include visceral fat reducing health functional food named Obi-X. In addition, the Company is engaged in the manufacturing and sale of anti-wrinkle cosmetics and deep-sea beard toothpastes. The Company distributes its products within the domestic market and to overseas markets, including America, Europe and Australia.